AP NEWS

Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 - ResearchAndMarkets.com

August 29, 2018

DUBLIN--(BUSINESS WIRE)--Aug 29, 2018--The “Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering.

Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 report provides comprehensive insights about marketed and Phase III products for Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD).

Coverage of API manufacturers for Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) marketed products spanning across United States, Europe, China and India. The manufacturers’ details include manufacturers’ name along with their location.

This report provides a comprehensive understanding of the emerging Phase III therapies for Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) which can turn out to be future prospective competitors for the marketed products. It will also put light on the current market trends. Their forecasted global sales are also provided till 2020.

Key Topics Covered:

1. Report Introduction

2. Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD): Overview

3. Comparative Analysis of Marketed and Emerging Products

4. Marketed Therapies

5. Emerging Therapies (Phase III)

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/5k2gpr/peripheral?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180829005646/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Cardiovascular Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH CARDIOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/29/2018 02:02 PM/DISC: 08/29/2018 02:02 PM

http://www.businesswire.com/news/home/20180829005646/en

AP RADIO
Update hourly